3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma
666
Lymphoma, Non-Hodgkin
593
Leukemia, Lymphocytic, Chronic, B-Cell
535
Precursor Cell Lymphoblastic Leukemia-Lymphoma
485
Lymphoma, Follicular
418
Lymphoma, Large B-Cell, Diffuse
379
Leukemia
358
Hodgkin Disease
354
Lymphoma, Mantle-Cell
306
Leukemia, Myeloid, Acute
250
Multiple Myeloma
237
Myelodysplastic Syndromes
214
Lymphoma, B-Cell, Marginal Zone
196
Recurrence
195
Burkitt Lymphoma
189
Waldenstrom Macroglobulinemia
155
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
130
Lymphoma, B-Cell
127
Neoplasms
118
Lymphoma, T-Cell, Cutaneous
116
Lymphoma, Large-Cell, Anaplastic
113
Hematologic Neoplasms
103
Lymphoma, Large-Cell, Immunoblastic
100
Mycosis Fungoides
95
Myeloproliferative Disorders
94
Sezary Syndrome
86
Lymphoma, T-Cell, Peripheral
83
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
81
Lymphoma, T-Cell
74
Primary Myelofibrosis
70
Interventions
Beclomethasone
1
Azithromycin
1
Amoxicillin-Potassium Clavulanate Combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Respiratory Sounds
×
Lymphoid
×
Clear all
NCT02517099
2023-03-06
PrIGMa
Imperial College London
Phase 2
Completed
60 enrolled
10 charts